Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-09 (Snapshot)
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high-frequency chest wall oscillation (HFCWO) therapy in lung care for patients of all ages in the United States. and internationally. The company is headquartered in New Prague, Minnesota.
52W High
$35.56
52W Low
$16.58
MA Status:
50D: Above
200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.54
Valuation
Fair
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
28.79
Forward P/E (<15 better)
23.53
EV/EBITDA (<8 favorable)
17.45
EV/Revenue (<3 favorable)
2.95
P/S (TTM) (<3 favorable)
3.19
P/B (<3 favorable)
4.73
Ownership
BalancedSource: Overview
Insiders (1–5% typical)
21.30%
Institutions (25–75% balanced)
53.27%
Shares Outstanding
8,349,200
Float
6,616,600
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
64,000,000
Gross Profit (TTM)
49,971,000
EPS (TTM)
0.85
Profit Margin (>10% good)
0.12%
Operating Margin (TTM) (higher better)
0.19%
ROE (TTM) (>15% strong)
0.17%
EPS YoY (Quarterly) (>10% good)
0.32
Revenue YoY (Quarterly) (>8% good)
0.17
Momentum
Bearish momentumValue
1.6138
Previous
1.7841
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025